|
For Deep venous Thrombosis (DVT)and Pulmonary Embolism (PE)
Obtain PTT, INR, CBC prior to initiating heparin. Obtain platelet count
on day 4 then every 3 days for two weeks.
Consider obtaining functional protein C, functional protein S, antithrombin III,
factor V Leiden and prothrombin G20210A mutation analysis, anticardiolipin
antibodies, and lupus anticoagulant .
Notify physician if platelet count is less than 100 K , hemoglobin drops by
more than 1 gram from baseline, or other abnormal values.
Ongoing monitoring:
(1) Order an aPTT 6 hours after any dosage change.
(This interval approximates four half-lives of heparin, the time
required to achieve steady-state kinetics.)
(2) Once 2 consecutive aPTTs are within the therapeutic range, monitor the aPTT
every 24 hours and adjust infusion accordingly.
All calculations must be confirmed before use. The suggested results are not a substitute for clinical
judgment. Neither OBFocus.com nor any other party involved in the preparation or publication of this site shall be liable for any special, consequential,
or exemplary damages resulting in whole or part from any user's use of or reliance upon this material.
REFERENCE: Raschke RA, Reilly BM, et al., The weight-based heparin dosing
nomogram compared with a "standard care" nomogram. A randomized controlled
trial. Ann Intern Med. 1993 Nov 1;119(9):874-81.PMID:8214998
|